Global Drug-eluting Coronary Stents Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Drug-eluting Coronary Stents which is coated with medication that reduces the risk of the artery becoming blocked again
The global market for Drug-eluting Coronary Stents is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug-eluting Coronary Stents players cover Medtronic, Boston Scientific, Biosensors, Terumo and MicroPort, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug-eluting Coronary Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug-eluting Coronary Stents market, with both quantitative and qualitative data, to help readers understand how the Drug-eluting Coronary Stents market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Drug-eluting Coronary Stents market and forecasts the market size by Type (Stent Diameter ?4mm and Stent Diameter ?4mm,), by Application (ASCs, Hospitals, Cardiology Center and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Drug-eluting Coronary Stents, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug-eluting Coronary Stents market size (sales and revenue) and CAGR, Drug-eluting Coronary Stents market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug-eluting Coronary Stents sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug-eluting Coronary Stents sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug-eluting Coronary Stents market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical and SINOMED, etc.
Chapter 14: Research Findings and Conclusion
Drug-eluting Coronary Stents which is coated with medication that reduces the risk of the artery becoming blocked again
The global market for Drug-eluting Coronary Stents is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug-eluting Coronary Stents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug-eluting Coronary Stents players cover Medtronic, Boston Scientific, Biosensors, Terumo and MicroPort, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug-eluting Coronary Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug-eluting Coronary Stents market, with both quantitative and qualitative data, to help readers understand how the Drug-eluting Coronary Stents market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Drug-eluting Coronary Stents market and forecasts the market size by Type (Stent Diameter ?4mm and Stent Diameter ?4mm,), by Application (ASCs, Hospitals, Cardiology Center and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Stent Diameter ?4mm
- Stent Diameter ?4mm
- ASCs
- Hospitals
- Cardiology Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- Biosensors
- Terumo
- MicroPort
- Lepu Medical
- B.Braun
- Atrium Medical
- SINOMED
- LBC
- Essen Technology
Chapter 1: Scope of Drug-eluting Coronary Stents, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug-eluting Coronary Stents market size (sales and revenue) and CAGR, Drug-eluting Coronary Stents market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug-eluting Coronary Stents sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug-eluting Coronary Stents sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug-eluting Coronary Stents market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical and SINOMED, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-eluting Coronary Stents Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drug-eluting Coronary Stents by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drug-eluting Coronary Stents by Country/Region, 2017, 2022 & 2028
2.2 Drug-eluting Coronary Stents Segment by Type
2.2.1 Stent Diameter ?4mm
2.2.2 Stent Diameter ?4mm
2.3 Drug-eluting Coronary Stents Sales by Type
2.3.1 Global Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
2.3.2 Global Drug-eluting Coronary Stents Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drug-eluting Coronary Stents Sale Price by Type (2017-2022)
2.4 Drug-eluting Coronary Stents Segment by Application
2.4.1 ASCs
2.4.2 Hospitals
2.4.3 Cardiology Center
2.4.4 Others
2.5 Drug-eluting Coronary Stents Sales by Application
2.5.1 Global Drug-eluting Coronary Stents Sale Market Share by Application (2017-2022)
2.5.2 Global Drug-eluting Coronary Stents Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drug-eluting Coronary Stents Sale Price by Application (2017-2022)
3 GLOBAL DRUG-ELUTING CORONARY STENTS BY COMPANY
3.1 Global Drug-eluting Coronary Stents Breakdown Data by Company
3.1.1 Global Drug-eluting Coronary Stents Annual Sales by Company (2020-2022)
3.1.2 Global Drug-eluting Coronary Stents Sales Market Share by Company (2020-2022)
3.2 Global Drug-eluting Coronary Stents Annual Revenue by Company (2020-2022)
3.2.1 Global Drug-eluting Coronary Stents Revenue by Company (2020-2022)
3.2.2 Global Drug-eluting Coronary Stents Revenue Market Share by Company (2020-2022)
3.3 Global Drug-eluting Coronary Stents Sale Price by Company
3.4 Key Manufacturers Drug-eluting Coronary Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-eluting Coronary Stents Product Location Distribution
3.4.2 Players Drug-eluting Coronary Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-ELUTING CORONARY STENTS BY GEOGRAPHIC REGION
4.1 World Historic Drug-eluting Coronary Stents Market Size by Geographic Region (2017-2022)
4.1.1 Global Drug-eluting Coronary Stents Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drug-eluting Coronary Stents Annual Revenue by Geographic Region
4.2 World Historic Drug-eluting Coronary Stents Market Size by Country/Region (2017-2022)
4.2.1 Global Drug-eluting Coronary Stents Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drug-eluting Coronary Stents Annual Revenue by Country/Region
4.3 Americas Drug-eluting Coronary Stents Sales Growth
4.4 APAC Drug-eluting Coronary Stents Sales Growth
4.5 Europe Drug-eluting Coronary Stents Sales Growth
4.6 Middle East & Africa Drug-eluting Coronary Stents Sales Growth
5 AMERICAS
5.1 Americas Drug-eluting Coronary Stents Sales by Country
5.1.1 Americas Drug-eluting Coronary Stents Sales by Country (2017-2022)
5.1.2 Americas Drug-eluting Coronary Stents Revenue by Country (2017-2022)
5.2 Americas Drug-eluting Coronary Stents Sales by Type
5.3 Americas Drug-eluting Coronary Stents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-eluting Coronary Stents Sales by Region
6.1.1 APAC Drug-eluting Coronary Stents Sales by Region (2017-2022)
6.1.2 APAC Drug-eluting Coronary Stents Revenue by Region (2017-2022)
6.2 APAC Drug-eluting Coronary Stents Sales by Type
6.3 APAC Drug-eluting Coronary Stents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-eluting Coronary Stents by Country
7.1.1 Europe Drug-eluting Coronary Stents Sales by Country (2017-2022)
7.1.2 Europe Drug-eluting Coronary Stents Revenue by Country (2017-2022)
7.2 Europe Drug-eluting Coronary Stents Sales by Type
7.3 Europe Drug-eluting Coronary Stents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-eluting Coronary Stents by Country
8.1.1 Middle East & Africa Drug-eluting Coronary Stents Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drug-eluting Coronary Stents Revenue by Country (2017-2022)
8.2 Middle East & Africa Drug-eluting Coronary Stents Sales by Type
8.3 Middle East & Africa Drug-eluting Coronary Stents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-eluting Coronary Stents
10.3 Manufacturing Process Analysis of Drug-eluting Coronary Stents
10.4 Industry Chain Structure of Drug-eluting Coronary Stents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-eluting Coronary Stents Distributors
11.3 Drug-eluting Coronary Stents Customer
12 WORLD FORECAST REVIEW FOR DRUG-ELUTING CORONARY STENTS BY GEOGRAPHIC REGION
12.1 Global Drug-eluting Coronary Stents Market Size Forecast by Region
12.1.1 Global Drug-eluting Coronary Stents Forecast by Region (2023-2028)
12.1.2 Global Drug-eluting Coronary Stents Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-eluting Coronary Stents Forecast by Type
12.7 Global Drug-eluting Coronary Stents Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug-eluting Coronary Stents Product Offered
13.1.3 Medtronic Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Drug-eluting Coronary Stents Product Offered
13.2.3 Boston Scientific Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Biosensors
13.3.1 Biosensors Company Information
13.3.2 Biosensors Drug-eluting Coronary Stents Product Offered
13.3.3 Biosensors Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biosensors Main Business Overview
13.3.5 Biosensors Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Drug-eluting Coronary Stents Product Offered
13.4.3 Terumo Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 MicroPort
13.5.1 MicroPort Company Information
13.5.2 MicroPort Drug-eluting Coronary Stents Product Offered
13.5.3 MicroPort Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MicroPort Main Business Overview
13.5.5 MicroPort Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Drug-eluting Coronary Stents Product Offered
13.6.3 Lepu Medical Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 B.Braun
13.7.1 B.Braun Company Information
13.7.2 B.Braun Drug-eluting Coronary Stents Product Offered
13.7.3 B.Braun Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 B.Braun Main Business Overview
13.7.5 B.Braun Latest Developments
13.8 Atrium Medical
13.8.1 Atrium Medical Company Information
13.8.2 Atrium Medical Drug-eluting Coronary Stents Product Offered
13.8.3 Atrium Medical Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Atrium Medical Main Business Overview
13.8.5 Atrium Medical Latest Developments
13.9 SINOMED
13.9.1 SINOMED Company Information
13.9.2 SINOMED Drug-eluting Coronary Stents Product Offered
13.9.3 SINOMED Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SINOMED Main Business Overview
13.9.5 SINOMED Latest Developments
13.10 LBC
13.10.1 LBC Company Information
13.10.2 LBC Drug-eluting Coronary Stents Product Offered
13.10.3 LBC Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 LBC Main Business Overview
13.10.5 LBC Latest Developments
13.11 Essen Technology
13.11.1 Essen Technology Company Information
13.11.2 Essen Technology Drug-eluting Coronary Stents Product Offered
13.11.3 Essen Technology Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Essen Technology Main Business Overview
13.11.5 Essen Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-eluting Coronary Stents Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drug-eluting Coronary Stents by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drug-eluting Coronary Stents by Country/Region, 2017, 2022 & 2028
2.2 Drug-eluting Coronary Stents Segment by Type
2.2.1 Stent Diameter ?4mm
2.2.2 Stent Diameter ?4mm
2.3 Drug-eluting Coronary Stents Sales by Type
2.3.1 Global Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
2.3.2 Global Drug-eluting Coronary Stents Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drug-eluting Coronary Stents Sale Price by Type (2017-2022)
2.4 Drug-eluting Coronary Stents Segment by Application
2.4.1 ASCs
2.4.2 Hospitals
2.4.3 Cardiology Center
2.4.4 Others
2.5 Drug-eluting Coronary Stents Sales by Application
2.5.1 Global Drug-eluting Coronary Stents Sale Market Share by Application (2017-2022)
2.5.2 Global Drug-eluting Coronary Stents Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drug-eluting Coronary Stents Sale Price by Application (2017-2022)
3 GLOBAL DRUG-ELUTING CORONARY STENTS BY COMPANY
3.1 Global Drug-eluting Coronary Stents Breakdown Data by Company
3.1.1 Global Drug-eluting Coronary Stents Annual Sales by Company (2020-2022)
3.1.2 Global Drug-eluting Coronary Stents Sales Market Share by Company (2020-2022)
3.2 Global Drug-eluting Coronary Stents Annual Revenue by Company (2020-2022)
3.2.1 Global Drug-eluting Coronary Stents Revenue by Company (2020-2022)
3.2.2 Global Drug-eluting Coronary Stents Revenue Market Share by Company (2020-2022)
3.3 Global Drug-eluting Coronary Stents Sale Price by Company
3.4 Key Manufacturers Drug-eluting Coronary Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-eluting Coronary Stents Product Location Distribution
3.4.2 Players Drug-eluting Coronary Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-ELUTING CORONARY STENTS BY GEOGRAPHIC REGION
4.1 World Historic Drug-eluting Coronary Stents Market Size by Geographic Region (2017-2022)
4.1.1 Global Drug-eluting Coronary Stents Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drug-eluting Coronary Stents Annual Revenue by Geographic Region
4.2 World Historic Drug-eluting Coronary Stents Market Size by Country/Region (2017-2022)
4.2.1 Global Drug-eluting Coronary Stents Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drug-eluting Coronary Stents Annual Revenue by Country/Region
4.3 Americas Drug-eluting Coronary Stents Sales Growth
4.4 APAC Drug-eluting Coronary Stents Sales Growth
4.5 Europe Drug-eluting Coronary Stents Sales Growth
4.6 Middle East & Africa Drug-eluting Coronary Stents Sales Growth
5 AMERICAS
5.1 Americas Drug-eluting Coronary Stents Sales by Country
5.1.1 Americas Drug-eluting Coronary Stents Sales by Country (2017-2022)
5.1.2 Americas Drug-eluting Coronary Stents Revenue by Country (2017-2022)
5.2 Americas Drug-eluting Coronary Stents Sales by Type
5.3 Americas Drug-eluting Coronary Stents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-eluting Coronary Stents Sales by Region
6.1.1 APAC Drug-eluting Coronary Stents Sales by Region (2017-2022)
6.1.2 APAC Drug-eluting Coronary Stents Revenue by Region (2017-2022)
6.2 APAC Drug-eluting Coronary Stents Sales by Type
6.3 APAC Drug-eluting Coronary Stents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-eluting Coronary Stents by Country
7.1.1 Europe Drug-eluting Coronary Stents Sales by Country (2017-2022)
7.1.2 Europe Drug-eluting Coronary Stents Revenue by Country (2017-2022)
7.2 Europe Drug-eluting Coronary Stents Sales by Type
7.3 Europe Drug-eluting Coronary Stents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-eluting Coronary Stents by Country
8.1.1 Middle East & Africa Drug-eluting Coronary Stents Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drug-eluting Coronary Stents Revenue by Country (2017-2022)
8.2 Middle East & Africa Drug-eluting Coronary Stents Sales by Type
8.3 Middle East & Africa Drug-eluting Coronary Stents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-eluting Coronary Stents
10.3 Manufacturing Process Analysis of Drug-eluting Coronary Stents
10.4 Industry Chain Structure of Drug-eluting Coronary Stents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-eluting Coronary Stents Distributors
11.3 Drug-eluting Coronary Stents Customer
12 WORLD FORECAST REVIEW FOR DRUG-ELUTING CORONARY STENTS BY GEOGRAPHIC REGION
12.1 Global Drug-eluting Coronary Stents Market Size Forecast by Region
12.1.1 Global Drug-eluting Coronary Stents Forecast by Region (2023-2028)
12.1.2 Global Drug-eluting Coronary Stents Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-eluting Coronary Stents Forecast by Type
12.7 Global Drug-eluting Coronary Stents Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug-eluting Coronary Stents Product Offered
13.1.3 Medtronic Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Drug-eluting Coronary Stents Product Offered
13.2.3 Boston Scientific Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Biosensors
13.3.1 Biosensors Company Information
13.3.2 Biosensors Drug-eluting Coronary Stents Product Offered
13.3.3 Biosensors Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biosensors Main Business Overview
13.3.5 Biosensors Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Drug-eluting Coronary Stents Product Offered
13.4.3 Terumo Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 MicroPort
13.5.1 MicroPort Company Information
13.5.2 MicroPort Drug-eluting Coronary Stents Product Offered
13.5.3 MicroPort Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MicroPort Main Business Overview
13.5.5 MicroPort Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Drug-eluting Coronary Stents Product Offered
13.6.3 Lepu Medical Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 B.Braun
13.7.1 B.Braun Company Information
13.7.2 B.Braun Drug-eluting Coronary Stents Product Offered
13.7.3 B.Braun Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 B.Braun Main Business Overview
13.7.5 B.Braun Latest Developments
13.8 Atrium Medical
13.8.1 Atrium Medical Company Information
13.8.2 Atrium Medical Drug-eluting Coronary Stents Product Offered
13.8.3 Atrium Medical Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Atrium Medical Main Business Overview
13.8.5 Atrium Medical Latest Developments
13.9 SINOMED
13.9.1 SINOMED Company Information
13.9.2 SINOMED Drug-eluting Coronary Stents Product Offered
13.9.3 SINOMED Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SINOMED Main Business Overview
13.9.5 SINOMED Latest Developments
13.10 LBC
13.10.1 LBC Company Information
13.10.2 LBC Drug-eluting Coronary Stents Product Offered
13.10.3 LBC Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 LBC Main Business Overview
13.10.5 LBC Latest Developments
13.11 Essen Technology
13.11.1 Essen Technology Company Information
13.11.2 Essen Technology Drug-eluting Coronary Stents Product Offered
13.11.3 Essen Technology Drug-eluting Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Essen Technology Main Business Overview
13.11.5 Essen Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug-eluting Coronary Stents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drug-eluting Coronary Stents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Stent Diameter ?4mm
Table 4. Major Players of Stent Diameter ?4mm
Table 5. Global Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 6. Global Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 7. Global Drug-eluting Coronary Stents Revenue by Type (2017-2022) & ($ million)
Table 8. Global Drug-eluting Coronary Stents Revenue Market Share by Type (2017-2022)
Table 9. Global Drug-eluting Coronary Stents Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 11. Global Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 12. Global Drug-eluting Coronary Stents Revenue by Application (2017-2022)
Table 13. Global Drug-eluting Coronary Stents Revenue Market Share by Application (2017-2022)
Table 14. Global Drug-eluting Coronary Stents Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Drug-eluting Coronary Stents Sales by Company (2020-2022) & (K Units)
Table 16. Global Drug-eluting Coronary Stents Sales Market Share by Company (2020-2022)
Table 17. Global Drug-eluting Coronary Stents Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Drug-eluting Coronary Stents Revenue Market Share by Company (2020-2022)
Table 19. Global Drug-eluting Coronary Stents Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Drug-eluting Coronary Stents Producing Area Distribution and Sales Area
Table 21. Players Drug-eluting Coronary Stents Products Offered
Table 22. Drug-eluting Coronary Stents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drug-eluting Coronary Stents Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Drug-eluting Coronary Stents Sales Market Share Geographic Region (2017-2022)
Table 27. Global Drug-eluting Coronary Stents Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Drug-eluting Coronary Stents Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Drug-eluting Coronary Stents Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Drug-eluting Coronary Stents Sales Market Share by Country/Region (2017-2022)
Table 31. Global Drug-eluting Coronary Stents Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Drug-eluting Coronary Stents Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Drug-eluting Coronary Stents Sales by Country (2017-2022) & (K Units)
Table 34. Americas Drug-eluting Coronary Stents Sales Market Share by Country (2017-2022)
Table 35. Americas Drug-eluting Coronary Stents Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Drug-eluting Coronary Stents Revenue Market Share by Country (2017-2022)
Table 37. Americas Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 38. Americas Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 39. Americas Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 40. Americas Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 41. APAC Drug-eluting Coronary Stents Sales by Region (2017-2022) & (K Units)
Table 42. APAC Drug-eluting Coronary Stents Sales Market Share by Region (2017-2022)
Table 43. APAC Drug-eluting Coronary Stents Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Drug-eluting Coronary Stents Revenue Market Share by Region (2017-2022)
Table 45. APAC Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 46. APAC Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 47. APAC Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 48. APAC Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 49. Europe Drug-eluting Coronary Stents Sales by Country (2017-2022) & (K Units)
Table 50. Europe Drug-eluting Coronary Stents Sales Market Share by Country (2017-2022)
Table 51. Europe Drug-eluting Coronary Stents Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Drug-eluting Coronary Stents Revenue Market Share by Country (2017-2022)
Table 53. Europe Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 54. Europe Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 55. Europe Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 56. Europe Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Drug-eluting Coronary Stents Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Drug-eluting Coronary Stents Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Drug-eluting Coronary Stents Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Drug-eluting Coronary Stents
Table 66. Key Market Challenges & Risks of Drug-eluting Coronary Stents
Table 67. Key Industry Trends of Drug-eluting Coronary Stents
Table 68. Drug-eluting Coronary Stents Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Drug-eluting Coronary Stents Distributors List
Table 71. Drug-eluting Coronary Stents Customer List
Table 72. Global Drug-eluting Coronary Stents Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Drug-eluting Coronary Stents Sales Market Forecast by Region
Table 74. Global Drug-eluting Coronary Stents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Drug-eluting Coronary Stents Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Drug-eluting Coronary Stents Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Drug-eluting Coronary Stents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Drug-eluting Coronary Stents Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Drug-eluting Coronary Stents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Drug-eluting Coronary Stents Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Drug-eluting Coronary Stents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Drug-eluting Coronary Stents Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Drug-eluting Coronary Stents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Drug-eluting Coronary Stents Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Drug-eluting Coronary Stents Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Drug-eluting Coronary Stents Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Drug-eluting Coronary Stents Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Drug-eluting Coronary Stents Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Drug-eluting Coronary Stents Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Drug-eluting Coronary Stents Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Drug-eluting Coronary Stents Revenue Market Share Forecast by Application (2023-2028)
Table 92. Medtronic Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 93. Medtronic Drug-eluting Coronary Stents Product Offered
Table 94. Medtronic Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Medtronic Main Business
Table 96. Medtronic Latest Developments
Table 97. Boston Scientific Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific Drug-eluting Coronary Stents Product Offered
Table 99. Boston Scientific Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Boston Scientific Main Business
Table 101. Boston Scientific Latest Developments
Table 102. Biosensors Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 103. Biosensors Drug-eluting Coronary Stents Product Offered
Table 104. Biosensors Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Biosensors Main Business
Table 106. Biosensors Latest Developments
Table 107. Terumo Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 108. Terumo Drug-eluting Coronary Stents Product Offered
Table 109. Terumo Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Terumo Main Business
Table 111. Terumo Latest Developments
Table 112. MicroPort Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 113. MicroPort Drug-eluting Coronary Stents Product Offered
Table 114. MicroPort Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. MicroPort Main Business
Table 116. MicroPort Latest Developments
Table 117. Lepu Medical Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 118. Lepu Medical Drug-eluting Coronary Stents Product Offered
Table 119. Lepu Medical Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Lepu Medical Main Business
Table 121. Lepu Medical Latest Developments
Table 122. B.Braun Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 123. B.Braun Drug-eluting Coronary Stents Product Offered
Table 124. B.Braun Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. B.Braun Main Business
Table 126. B.Braun Latest Developments
Table 127. Atrium Medical Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 128. Atrium Medical Drug-eluting Coronary Stents Product Offered
Table 129. Atrium Medical Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Atrium Medical Main Business
Table 131. Atrium Medical Latest Developments
Table 132. SINOMED Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 133. SINOMED Drug-eluting Coronary Stents Product Offered
Table 134. SINOMED Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. SINOMED Main Business
Table 136. SINOMED Latest Developments
Table 137. LBC Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 138. LBC Drug-eluting Coronary Stents Product Offered
Table 139. LBC Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. LBC Main Business
Table 141. LBC Latest Developments
Table 142. Essen Technology Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 143. Essen Technology Drug-eluting Coronary Stents Product Offered
Table 144. Essen Technology Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Essen Technology Main Business
Table 146. Essen Technology Latest Developments
Table 1. Drug-eluting Coronary Stents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drug-eluting Coronary Stents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Stent Diameter ?4mm
Table 4. Major Players of Stent Diameter ?4mm
Table 5. Global Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 6. Global Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 7. Global Drug-eluting Coronary Stents Revenue by Type (2017-2022) & ($ million)
Table 8. Global Drug-eluting Coronary Stents Revenue Market Share by Type (2017-2022)
Table 9. Global Drug-eluting Coronary Stents Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 11. Global Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 12. Global Drug-eluting Coronary Stents Revenue by Application (2017-2022)
Table 13. Global Drug-eluting Coronary Stents Revenue Market Share by Application (2017-2022)
Table 14. Global Drug-eluting Coronary Stents Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Drug-eluting Coronary Stents Sales by Company (2020-2022) & (K Units)
Table 16. Global Drug-eluting Coronary Stents Sales Market Share by Company (2020-2022)
Table 17. Global Drug-eluting Coronary Stents Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Drug-eluting Coronary Stents Revenue Market Share by Company (2020-2022)
Table 19. Global Drug-eluting Coronary Stents Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Drug-eluting Coronary Stents Producing Area Distribution and Sales Area
Table 21. Players Drug-eluting Coronary Stents Products Offered
Table 22. Drug-eluting Coronary Stents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drug-eluting Coronary Stents Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Drug-eluting Coronary Stents Sales Market Share Geographic Region (2017-2022)
Table 27. Global Drug-eluting Coronary Stents Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Drug-eluting Coronary Stents Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Drug-eluting Coronary Stents Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Drug-eluting Coronary Stents Sales Market Share by Country/Region (2017-2022)
Table 31. Global Drug-eluting Coronary Stents Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Drug-eluting Coronary Stents Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Drug-eluting Coronary Stents Sales by Country (2017-2022) & (K Units)
Table 34. Americas Drug-eluting Coronary Stents Sales Market Share by Country (2017-2022)
Table 35. Americas Drug-eluting Coronary Stents Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Drug-eluting Coronary Stents Revenue Market Share by Country (2017-2022)
Table 37. Americas Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 38. Americas Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 39. Americas Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 40. Americas Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 41. APAC Drug-eluting Coronary Stents Sales by Region (2017-2022) & (K Units)
Table 42. APAC Drug-eluting Coronary Stents Sales Market Share by Region (2017-2022)
Table 43. APAC Drug-eluting Coronary Stents Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Drug-eluting Coronary Stents Revenue Market Share by Region (2017-2022)
Table 45. APAC Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 46. APAC Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 47. APAC Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 48. APAC Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 49. Europe Drug-eluting Coronary Stents Sales by Country (2017-2022) & (K Units)
Table 50. Europe Drug-eluting Coronary Stents Sales Market Share by Country (2017-2022)
Table 51. Europe Drug-eluting Coronary Stents Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Drug-eluting Coronary Stents Revenue Market Share by Country (2017-2022)
Table 53. Europe Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 54. Europe Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 55. Europe Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 56. Europe Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Drug-eluting Coronary Stents Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Drug-eluting Coronary Stents Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Drug-eluting Coronary Stents Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Drug-eluting Coronary Stents Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Drug-eluting Coronary Stents Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Drug-eluting Coronary Stents
Table 66. Key Market Challenges & Risks of Drug-eluting Coronary Stents
Table 67. Key Industry Trends of Drug-eluting Coronary Stents
Table 68. Drug-eluting Coronary Stents Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Drug-eluting Coronary Stents Distributors List
Table 71. Drug-eluting Coronary Stents Customer List
Table 72. Global Drug-eluting Coronary Stents Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Drug-eluting Coronary Stents Sales Market Forecast by Region
Table 74. Global Drug-eluting Coronary Stents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Drug-eluting Coronary Stents Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Drug-eluting Coronary Stents Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Drug-eluting Coronary Stents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Drug-eluting Coronary Stents Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Drug-eluting Coronary Stents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Drug-eluting Coronary Stents Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Drug-eluting Coronary Stents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Drug-eluting Coronary Stents Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Drug-eluting Coronary Stents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Drug-eluting Coronary Stents Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Drug-eluting Coronary Stents Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Drug-eluting Coronary Stents Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Drug-eluting Coronary Stents Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Drug-eluting Coronary Stents Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Drug-eluting Coronary Stents Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Drug-eluting Coronary Stents Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Drug-eluting Coronary Stents Revenue Market Share Forecast by Application (2023-2028)
Table 92. Medtronic Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 93. Medtronic Drug-eluting Coronary Stents Product Offered
Table 94. Medtronic Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Medtronic Main Business
Table 96. Medtronic Latest Developments
Table 97. Boston Scientific Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific Drug-eluting Coronary Stents Product Offered
Table 99. Boston Scientific Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Boston Scientific Main Business
Table 101. Boston Scientific Latest Developments
Table 102. Biosensors Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 103. Biosensors Drug-eluting Coronary Stents Product Offered
Table 104. Biosensors Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Biosensors Main Business
Table 106. Biosensors Latest Developments
Table 107. Terumo Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 108. Terumo Drug-eluting Coronary Stents Product Offered
Table 109. Terumo Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Terumo Main Business
Table 111. Terumo Latest Developments
Table 112. MicroPort Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 113. MicroPort Drug-eluting Coronary Stents Product Offered
Table 114. MicroPort Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. MicroPort Main Business
Table 116. MicroPort Latest Developments
Table 117. Lepu Medical Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 118. Lepu Medical Drug-eluting Coronary Stents Product Offered
Table 119. Lepu Medical Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Lepu Medical Main Business
Table 121. Lepu Medical Latest Developments
Table 122. B.Braun Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 123. B.Braun Drug-eluting Coronary Stents Product Offered
Table 124. B.Braun Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. B.Braun Main Business
Table 126. B.Braun Latest Developments
Table 127. Atrium Medical Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 128. Atrium Medical Drug-eluting Coronary Stents Product Offered
Table 129. Atrium Medical Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Atrium Medical Main Business
Table 131. Atrium Medical Latest Developments
Table 132. SINOMED Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 133. SINOMED Drug-eluting Coronary Stents Product Offered
Table 134. SINOMED Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. SINOMED Main Business
Table 136. SINOMED Latest Developments
Table 137. LBC Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 138. LBC Drug-eluting Coronary Stents Product Offered
Table 139. LBC Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. LBC Main Business
Table 141. LBC Latest Developments
Table 142. Essen Technology Basic Information, Drug-eluting Coronary Stents Manufacturing Base, Sales Area and Its Competitors
Table 143. Essen Technology Drug-eluting Coronary Stents Product Offered
Table 144. Essen Technology Drug-eluting Coronary Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Essen Technology Main Business
Table 146. Essen Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug-eluting Coronary Stents
Figure 2. Drug-eluting Coronary Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-eluting Coronary Stents Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drug-eluting Coronary Stents Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drug-eluting Coronary Stents Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Stent Diameter ?4mm
Figure 10. Product Picture of Stent Diameter ?4mm
Figure 11. Global Drug-eluting Coronary Stents Sales Market Share by Type in 2021
Figure 12. Global Drug-eluting Coronary Stents Revenue Market Share by Type (2017-2022)
Figure 13. Drug-eluting Coronary Stents Consumed in ASCs
Figure 14. Global Drug-eluting Coronary Stents Market: ASCs (2017-2022) & (K Units)
Figure 15. Drug-eluting Coronary Stents Consumed in Hospitals
Figure 16. Global Drug-eluting Coronary Stents Market: Hospitals (2017-2022) & (K Units)
Figure 17. Drug-eluting Coronary Stents Consumed in Cardiology Center
Figure 18. Global Drug-eluting Coronary Stents Market: Cardiology Center (2017-2022) & (K Units)
Figure 19. Drug-eluting Coronary Stents Consumed in Others
Figure 20. Global Drug-eluting Coronary Stents Market: Others (2017-2022) & (K Units)
Figure 21. Global Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Figure 22. Global Drug-eluting Coronary Stents Revenue Market Share by Application in 2021
Figure 23. Drug-eluting Coronary Stents Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Drug-eluting Coronary Stents Revenue Market Share by Company in 2021
Figure 25. Global Drug-eluting Coronary Stents Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Drug-eluting Coronary Stents Revenue Market Share by Geographic Region in 2021
Figure 27. Global Drug-eluting Coronary Stents Sales Market Share by Region (2017-2022)
Figure 28. Global Drug-eluting Coronary Stents Revenue Market Share by Country/Region in 2021
Figure 29. Americas Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 30. Americas Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 31. APAC Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 32. APAC Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 33. Europe Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 34. Europe Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 37. Americas Drug-eluting Coronary Stents Sales Market Share by Country in 2021
Figure 38. Americas Drug-eluting Coronary Stents Revenue Market Share by Country in 2021
Figure 39. United States Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Drug-eluting Coronary Stents Sales Market Share by Region in 2021
Figure 44. APAC Drug-eluting Coronary Stents Revenue Market Share by Regions in 2021
Figure 45. China Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Drug-eluting Coronary Stents Sales Market Share by Country in 2021
Figure 52. Europe Drug-eluting Coronary Stents Revenue Market Share by Country in 2021
Figure 53. Germany Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Drug-eluting Coronary Stents Revenue Market Share by Country in 2021
Figure 60. Egypt Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Drug-eluting Coronary Stents in 2021
Figure 66. Manufacturing Process Analysis of Drug-eluting Coronary Stents
Figure 67. Industry Chain Structure of Drug-eluting Coronary Stents
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Drug-eluting Coronary Stents
Figure 2. Drug-eluting Coronary Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-eluting Coronary Stents Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drug-eluting Coronary Stents Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drug-eluting Coronary Stents Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Stent Diameter ?4mm
Figure 10. Product Picture of Stent Diameter ?4mm
Figure 11. Global Drug-eluting Coronary Stents Sales Market Share by Type in 2021
Figure 12. Global Drug-eluting Coronary Stents Revenue Market Share by Type (2017-2022)
Figure 13. Drug-eluting Coronary Stents Consumed in ASCs
Figure 14. Global Drug-eluting Coronary Stents Market: ASCs (2017-2022) & (K Units)
Figure 15. Drug-eluting Coronary Stents Consumed in Hospitals
Figure 16. Global Drug-eluting Coronary Stents Market: Hospitals (2017-2022) & (K Units)
Figure 17. Drug-eluting Coronary Stents Consumed in Cardiology Center
Figure 18. Global Drug-eluting Coronary Stents Market: Cardiology Center (2017-2022) & (K Units)
Figure 19. Drug-eluting Coronary Stents Consumed in Others
Figure 20. Global Drug-eluting Coronary Stents Market: Others (2017-2022) & (K Units)
Figure 21. Global Drug-eluting Coronary Stents Sales Market Share by Application (2017-2022)
Figure 22. Global Drug-eluting Coronary Stents Revenue Market Share by Application in 2021
Figure 23. Drug-eluting Coronary Stents Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Drug-eluting Coronary Stents Revenue Market Share by Company in 2021
Figure 25. Global Drug-eluting Coronary Stents Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Drug-eluting Coronary Stents Revenue Market Share by Geographic Region in 2021
Figure 27. Global Drug-eluting Coronary Stents Sales Market Share by Region (2017-2022)
Figure 28. Global Drug-eluting Coronary Stents Revenue Market Share by Country/Region in 2021
Figure 29. Americas Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 30. Americas Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 31. APAC Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 32. APAC Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 33. Europe Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 34. Europe Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Drug-eluting Coronary Stents Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Drug-eluting Coronary Stents Revenue 2017-2022 ($ Millions)
Figure 37. Americas Drug-eluting Coronary Stents Sales Market Share by Country in 2021
Figure 38. Americas Drug-eluting Coronary Stents Revenue Market Share by Country in 2021
Figure 39. United States Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Drug-eluting Coronary Stents Sales Market Share by Region in 2021
Figure 44. APAC Drug-eluting Coronary Stents Revenue Market Share by Regions in 2021
Figure 45. China Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Drug-eluting Coronary Stents Sales Market Share by Country in 2021
Figure 52. Europe Drug-eluting Coronary Stents Revenue Market Share by Country in 2021
Figure 53. Germany Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Drug-eluting Coronary Stents Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Drug-eluting Coronary Stents Revenue Market Share by Country in 2021
Figure 60. Egypt Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Drug-eluting Coronary Stents Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Drug-eluting Coronary Stents in 2021
Figure 66. Manufacturing Process Analysis of Drug-eluting Coronary Stents
Figure 67. Industry Chain Structure of Drug-eluting Coronary Stents
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
